Kenya has been awarded as the 98th membership to the WHO Programme for International Drug Monitoring. Through a letter dated 4th May 2010, signed by Dr. Lembit Rägo, Coordinator, Quality Assurance and Safety: Medicines, Essential…
November 19, 2010 — The US Food and Drug Administration (FDA) has asked that propoxyphene, sold under the brand names Darvon and Darvocet by Xanodyne Pharmaceuticals, be removed from the US market. The decision will…
January 21, 2011 — New data showing nonsteroidal anti-inflammatory drugs (NSAIDs) have cardiovascular risks are putting the well-known pain relievers back in the headlines. Investigators evaluating available evidence report they have found little to suggest…
The antidepressant citalopram should not be used in doses higher than 40 mg per day because of concerns that it can cause potentially fatal changes in heart rhythm, the US Food and Drug Administration warns.…

Introduction

The  Hospital Pharmacists Association of Kenya (HOPAK) provides a dynamic platform for the exchange of knowledge among sector players to enhance their contributions to health. We provide timely scientific programs, ongoing education, opportunities for networking, and professional development.

Our website is a resource portal for all practicing hospital and institutional pharmacists in Kenya.

Contact us

Hospital Pharmacists Association of Kenya (HOPAK)
P. O. Box 456 00202
Nairobi - Kenya
[email protected]

JoomShaper